14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ACOR ranks #14807 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Acorda Therapeutics Stock Forecast NASDAQ:ACOR

$4.06 (-1.46%)

Volume: 93k

Closed: Oct 25, 2021

Hollow Logo Score: -3.660

Acorda Therapeutics Stock Forecast

$4.06 (-1.46%)

Volume: 93k

Closed: Oct 25, 2021

Score Hollow Logo -3.660

Acorda Therapeutics Stock Price (Quote) NASDAQ:ACOR

$4.06 ( -1.46% ) Monday, 25th Oct 2021

Range Low Price High Price Comment
30 days $3.97 $4.94 Monday, 25th Oct 2021 ACOR stock ended at $4.06. This is 1.46% less than the trading day before Friday, 22nd Oct 2021. During the day the stock fluctuated 3.96% from a day low at $4.04 to a day high of $4.20.
90 days $3.27 $4.99
52 weeks $0.62 $8.66

Historical Acorda Therapeutics prices

Date Open High Low Close Volume
2021-10-25 $4.13 $4.20 $4.04 $4.06 93 270
2021-10-22 $4.30 $4.30 $4.02 $4.12 156 394
2021-10-21 $4.50 $4.60 $4.34 $4.36 45 026
2021-10-20 $4.60 $4.64 $4.40 $4.49 66 785
2021-10-19 $4.65 $4.83 $4.53 $4.61 108 425
2021-10-18 $4.71 $4.74 $4.55 $4.65 72 293
2021-10-15 $4.73 $4.90 $4.62 $4.71 111 125
2021-10-14 $4.63 $4.83 $4.63 $4.66 82 850
2021-10-13 $4.59 $4.74 $4.55 $4.63 68 453
2021-10-12 $4.54 $4.60 $4.44 $4.56 89 968
2021-10-11 $4.08 $4.75 $4.08 $4.49 247 926
2021-10-08 $4.11 $4.25 $4.00 $4.08 75 533
2021-10-07 $4.13 $4.25 $4.09 $4.15 52 241
2021-10-06 $4.09 $4.23 $4.01 $4.13 71 651
2021-10-05 $4.42 $4.43 $3.97 $4.14 220 152
2021-10-04 $4.63 $4.66 $4.42 $4.43 75 734
2021-10-01 $4.60 $4.67 $4.52 $4.64 59 887
2021-09-30 $4.75 $4.75 $4.58 $4.60 53 952
2021-09-29 $4.84 $4.85 $4.69 $4.69 63 913
2021-09-28 $4.71 $4.94 $4.69 $4.79 103 840
2021-09-27 $4.74 $4.89 $4.70 $4.73 53 877
2021-09-24 $4.39 $4.99 $4.36 $4.74 323 746
2021-09-23 $4.37 $4.49 $4.37 $4.46 41 546
2021-09-22 $4.28 $4.43 $4.27 $4.36 55 894
2021-09-21 $4.35 $4.53 $4.28 $4.28 100 994
2021-09-20 $4.61 $4.65 $4.26 $4.36 171 568
2021-09-17 $4.69 $4.90 $4.64 $4.73 143 946
2021-09-16 $4.60 $4.73 $4.48 $4.69 107 956
2021-09-15 $4.66 $4.77 $4.50 $4.65 78 033
2021-09-14 $4.71 $4.77 $4.61 $4.69 196 321
2021-09-13 $4.67 $4.72 $4.49 $4.70 139 490
2021-09-10 $4.56 $4.70 $4.48 $4.67 226 639
2021-09-09 $4.31 $4.55 $4.23 $4.46 142 437
2021-09-08 $4.13 $4.39 $4.00 $4.34 223 578
2021-09-07 $4.31 $4.45 $4.06 $4.17 205 590
2021-09-03 $4.32 $4.41 $4.28 $4.38 45 985
2021-09-02 $4.37 $4.45 $4.30 $4.35 100 699
2021-09-01 $4.25 $4.44 $4.18 $4.37 164 763
2021-08-31 $4.16 $4.39 $4.13 $4.23 272 307
2021-08-30 $4.25 $4.33 $4.08 $4.13 154 973
2021-08-27 $4.21 $4.49 $4.12 $4.28 281 427
2021-08-26 $4.22 $4.29 $4.06 $4.16 229 155
2021-08-25 $4.07 $4.24 $4.00 $4.20 126 923
2021-08-24 $3.98 $4.13 $3.92 $4.06 153 073
2021-08-23 $3.88 $3.99 $3.81 $3.98 181 036
2021-08-20 $3.71 $4.00 $3.68 $3.88 353 333
2021-08-19 $3.68 $3.78 $3.57 $3.64 98 674
2021-08-18 $3.60 $3.80 $3.48 $3.69 253 569
2021-08-17 $3.37 $3.70 $3.37 $3.60 249 932
2021-08-16 $3.50 $3.50 $3.36 $3.38 133 619

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Zanaflex Capsules and tablets for the management of spasticity; and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT